colchicine reduces lung injury in experimental acute respiratory distress syndrome
colchicine reduces lung injury in experimental acute respiratory distress syndrome
lung neutrophil recruitment was reduced by colchicine with evidence for reduced neutrophils activation, as assessed by flow cytometry.", "this study strongly supports the clinical development of colchicine, a widely available low-cost drug, for the prevention of ards in conditions causing acute lung injury.")